Saroja Pharma IPO vs Unihealth Consultancy IPO

Comparison between Saroja Pharma IPO and Unihealth Consultancy IPO.

IPO Details

Saroja Pharma IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Unihealth Consultancy IPO is a SME Bookbuilding proposed to list at NSE SME.

	Saroja Pharma IPO	Unihealth Consultancy IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Fixed Price	Bookbuilding
Listing At	NSE SME	NSE SME
Lead Managers	Swastika Investmart Ltd.	Unistone Capital Pvt.Ltd.
Registrar	Kfin Technologies Ltd.	Bigshare Services Pvt.Ltd.
Market Maker	Swastika Investmart Ltd.	Rikhav Securities Ltd.
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor		Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Saroja Pharma IPO is up to ₹8.66 Cr whereas the issue size of the Unihealth Consultancy IPO is up to ₹53.70 Cr. The final issue price of Saroja Pharma IPO is ₹84.00 per share and of Unihealth Consultancy IPO is ₹132.00 per share.

	Saroja Pharma IPO	Unihealth Consultancy IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)		₹126.00 per share
Issue Price (Upper)		₹132.00 per share
Issue Price (Final)	₹84.00 per share	₹132.00 per share
Discount (Retail)	₹0.00 per share	₹0.00 per share
Discount (Employee)
Market Lot Size	1600 shares	1000 shares
Fresh Issue Size	10,30,400 shares	40,68,000 shares
Fresh Issue Size (Amount)	up to ₹8.66 Cr	up to ₹53.70 Cr
OFS Issue Size	0 shares	0 shares
OFS Issue Size (Amount)	up to ₹0.00 Cr	up to ₹0.00 Cr
Issue Size Total	10,30,400 shares	40,68,000 shares
Issue Size Total (Amount)	up to ₹8.66 Cr	up to ₹53.70 Cr

IPO Timetable

Saroja Pharma IPO opens on Aug 31, 2023, while Unihealth Consultancy IPO opens on Sep 08, 2023. The closing date of Saroja Pharma IPO and Unihealth Consultancy IPO is Sep 05, 2023, and Sep 12, 2023, respectively.

	Saroja Pharma IPO	Unihealth Consultancy IPO
Anchor Bid Date		Sep 07, 2023
Issue Open	Aug 31, 2023	Sep 08, 2023
Issue Close	Sep 05, 2023	Sep 12, 2023
Basis Of Allotment (Tentative)	Sep 08, 2023	Sep 15, 2023
Initiation of Refunds (Tentative)	Sep 11, 2023	Sep 18, 2023
Credit of Share (Tentative)	Sep 12, 2023	Sep 20, 2023
Listing date (Tentative)	Sep 13, 2023	Sep 21, 2023
Anchor Lockin End date 1		Oct 15, 2023
Anchor Lockin End date 2		Dec 14, 2023

Financials & KPIs

Saroja Pharma IPO P/E ratio is 23.27, as compared to Unihealth Consultancy IPO P/E ratio of 19.02.

Saroja Pharma IPO

Unihealth Consultancy IPO

Financials

Saroja Pharma Industries IPO Financial Information (Restated Standalone)
Period Ended	31 Mar 2021	31 Mar 2022	31 Mar 2023
Assets	822.39	1,551.19	2,133.99
Total Income	3,674.67	5,595.67	5,035.09
Profit After Tax	73.13	114.01	106.06
Net Worth	93.59	402.60	508.66
Reserves and Surplus	92.59	380.02	215.09
Total Borrowing	301.77	613.88	1,018.86

Amount in ₹ Lakhs

Unihealth Consultancy IPO Financial Information (Restated Consolidated)
Period Ended	31 Mar 2021	31 Mar 2022	31 Mar 2023
Assets	5,838.87	6,478.65	7,833.32
Total Income	2,863.51	3,792.69	4,603.01
Profit After Tax	500.89	382.02	768.00
Net Worth	1,070.36	1,479.17	2,612.83
Reserves and Surplus	936.17	1,344.98	2,612.83
Total Borrowing	3,871.05	3,801.30	3,926.67

Amount in ₹ Lakhs

Promoter Shareholding (Pre-Issue)

100.00

95.32

Promoter Shareholding (Post-Issue)

73.02

P/E Ratio

23.27

19.02

Market Cap

₹33.77 Cr.

₹203.28 Cr.

ROE

0.15%

36.19%

ROCE

0.25%

20.99%

Debt/Equity

2.00

1.43

EPS

₹3.61

₹6.94

RoNW

20.85%

27.91%

Shares Offered

In the Saroja Pharma IPO Retail Individual Investors (RII) are offered 5,15,200 shares while in Unihealth Consultancy IPO retail investors are offered 5,15,200 shares. Qualified Institutional Buyers (QIB) are offered in Saroja Pharma IPO and 8,15,000 shares in Unihealth Consultancy IPO.

	Saroja Pharma IPO	Unihealth Consultancy IPO
Anchor Investor Reserveration		12,18,000 shares
Market Maker Reserveration	54,400 shares	2,16,000 shares
QIB		8,15,000 shares
NII	5,15,200 shares	6,11,000 shares
RII	5,15,200 shares	14,24,000 shares
Employee
Others
Total	10,30,400 shares	40,68,000 shares

Bids Received (Subscription)

Saroja Pharma IPO subscribed 8.88x in total, whereas Unihealth Consultancy IPO subscribed 18.22x.

	Saroja Pharma IPO	Unihealth Consultancy IPO
QIB (times)		5.97x
NII (times)	2.90x	37.65x
Big NII (times)
Small NII (times)
RII (times)	14.83x	24.61x
Employee (times)
Other (times)
Total (times)	8.88x	18.22x

Compare with others

Saroja Pharma IPO	Unihealth Consultancy IPO
Chavda Infra IPO	Cellecor Gadgets IPO
Jiwanram Sheoduttrai IPO	Kundan Edifice IPO
Unihealth Consultancy IPO	Meson Valves IPO
Kahan Packaging IPO	Chavda Infra IPO
Pramara Promotions IPO	Jiwanram Sheoduttrai IPO
Basilic Fly Studio IPO	Kahan Packaging IPO
C P S Shapers IPO	Pramara Promotions IPO
Mono Pharmacare IPO	Saroja Pharma IPO
Sungarner Energies IPO	Basilic Fly Studio IPO
Sahaj Fashions IPO	C P S Shapers IPO